Ashmore Group (LON:ASHM) investors are sitting on a loss of 39% if they invested five years ago
It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.
During the five years over which the share price declined, Ashmore Group's earnings per share (EPS) dropped by 19% each year. The share price decline of 16% per year isn't as bad as the EPS decline. The relatively muted share price reaction might be because the market expects the business to turn around.
The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).
Dive deeper into Ashmore Group's key metrics by checking this interactive graph of Ashmore Group's earnings, revenue and cash flow.
What About Dividends?
It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. In the case of Ashmore Group, it has a TSR of -39% for the last 5 years. That exceeds its share price return that we previously mentioned. The dividends paid by the company have thusly boosted the total shareholder return.
A Different Perspective
Ashmore Group provided a TSR of 11% over the year (including dividends). That's fairly close to the broader market return. The silver lining is that the share price is up in the short term, which flies in the face of the annualised loss of 7% over the last five years. We're pretty skeptical of turnaround stories, but it's good to see the recent share price recovery. It's always interesting to track share price performance over the longer term. But to understand Ashmore Group better, we need to consider many other factors. Case in point: We've spotted 3 warning signs for Ashmore Group you should be aware of, and 2 of them make us uncomfortable.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on British exchanges.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Errore nel recupero dei dati
Effettua l'accesso per consultare il tuo portafoglio
Errore nel recupero dei dati
Errore nel recupero dei dati
Errore nel recupero dei dati
Errore nel recupero dei dati
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Liverpool arrange meeting with European giant for MEGA transfer
Negotiators begin talks for mega deal The deal in question is for Luis Diaz to move to Bayern Munich, with the German giants interested. An approach has already been rejected for him, with Liverpool reiterating the 'not-for-sale' stance, but rumours are suggesting that there is a fee that could convince the Reds to sell - around €100m. But reports from Germany are suggesting that a meeting has been scheduled to begin serious talks. Christian Falk took to X on Saturday and said: "There will be a meeting between Bayern and Liverpool for negotiations for a transfer of Luis Diaz soon. The poker Poker is influenced by the transfer of Hugo Ekitike. Liverpool FC is preparing a mega offer of €100m for Ekitike. Should Liverpool get their desired player, they can invest the transfer fee of Diaz."
Yahoo
11 minutes ago
- Yahoo
Morgan Stanley Lifts PT on The Charles Schwab Corporation (SCHW) to $117, Keeps Overweight Rating
The Charles Schwab Corporation (NYSE:SCHW) is one of the best long term low volatility stocks to buy now. On July 15, Morgan Stanley raised the firm's price target on The Charles Schwab Corporation (NYSE:SCHW) to $117 from $83 while keeping an Overweight rating on the shares. A corporate finance professional studying a financial performance chart. The firm told investors that it has become increasingly selective as the market goes into the Q2 earnings season. It also added that it still sees scope for interest rates, inflation, and tariffs to support rates and credit volumes. The Charles Schwab Corporation (NYSE:SCHW) is a savings and loan holding company that engages in securities brokerage, wealth management, custody, asset management, and financial advisory services. Its operations are divided into Advisor Services and Investor Services segments. While we acknowledge the potential of SCHW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
37 minutes ago
- Yahoo
ASX Penny Stocks With Market Caps Over A$600M
The Australian sharemarket is set to follow Wall Street's record-setting trend, with the ASX 200 futures pointing to a positive end to the week amid U.S. economic signals and rising unemployment rates. In such a buoyant market atmosphere, investors often explore diverse opportunities, including penny stocks—an investment category that continues to intrigue despite its somewhat outdated label. These smaller or newer companies can offer significant potential when they possess strong financials and promising growth paths, providing an attractive option for those looking beyond the traditional blue-chip investments. Top 10 Penny Stocks In Australia Name Share Price Market Cap Financial Health Rating Alfabs Australia (ASX:AAL) A$0.415 A$118.93M ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$2.31 A$108.97M ★★★★★★ GTN (ASX:GTN) A$0.59 A$112.49M ★★★★★★ IVE Group (ASX:IGL) A$3.14 A$484.13M ★★★★★☆ West African Resources (ASX:WAF) A$2.25 A$2.56B ★★★★★★ Southern Cross Electrical Engineering (ASX:SXE) A$1.80 A$475.94M ★★★★★★ Regal Partners (ASX:RPL) A$2.66 A$894.36M ★★★★★★ Sugar Terminals (NSX:SUG) A$0.99 A$360M ★★★★★★ Bisalloy Steel Group (ASX:BIS) A$4.23 A$200.71M ★★★★★★ CTI Logistics (ASX:CLX) A$1.90 A$153.03M ★★★★☆☆ Click here to see the full list of 458 stocks from our ASX Penny Stocks screener. Let's explore several standout options from the results in the screener. Brazilian Rare Earths Simply Wall St Financial Health Rating: ★★★★★★ Overview: Brazilian Rare Earths Limited is engaged in the exploration of rare earth elements and other critical minerals in Brazil, with a market cap of A$670.54 million. Operations: Currently, there are no reported revenue segments for this company. Market Cap: A$670.54M Brazilian Rare Earths Limited, with a market cap of A$670.54 million, is a pre-revenue company focused on rare earth elements in Brazil. Recent advancements include successful production of high-purity mixed-rare earth carbonate and uranium peroxide from its Monte Alto Project, marking significant progress in its strategy to establish an integrated supply chain. Exploration at the Sulista Project revealed ultra-high-grade deposits and promising drill results, enhancing future potential. Although debt-free with sufficient cash runway for over a year, the company remains unprofitable and led by an inexperienced management team. Strategic alliances are underway to optimize mineral processing capabilities. Dive into the specifics of Brazilian Rare Earths here with our thorough balance sheet health report. Review our growth performance report to gain insights into Brazilian Rare Earths' future. HMC Capital Simply Wall St Financial Health Rating: ★★★★★☆ Overview: HMC Capital Limited, along with its subsidiaries, owns and manages real estate-focused funds in Australia and has a market capitalization of A$1.59 billion. Operations: HMC Capital generates revenue from its real estate segment, amounting to A$77.6 million. Market Cap: A$1.59B HMC Capital, with a market cap of A$1.59 billion, presents a mixed picture for investors interested in penny stocks. The company has shown substantial earnings growth over the past year at 289.9%, outperforming the industry average significantly. However, this growth includes a large one-off gain of A$130.1 million affecting recent results. HMC's valuation appears attractive as it trades below estimated fair value and maintains good relative value compared to peers. Despite having more cash than debt and covering interest payments comfortably, its operating cash flow coverage is weak, and future earnings are forecast to decline slightly over three years by an average of 1.5% annually. Click to explore a detailed breakdown of our findings in HMC Capital's financial health report. Gain insights into HMC Capital's outlook and expected performance with our report on the company's earnings estimates. United Overseas Australia Simply Wall St Financial Health Rating: ★★★★★★ Overview: United Overseas Australia Ltd, along with its subsidiaries, is involved in the development and resale of land and buildings across Malaysia, Singapore, Vietnam, and Australia with a market capitalization of A$1.02 billion. Operations: The company's revenue segments include the development and resale of land and buildings across Malaysia (MYR 1.72 billion), Singapore (MYR 1.14 billion), Vietnam (MYR 0.98 billion), and Australia (MYR 0.95 billion). Market Cap: A$1.02B United Overseas Australia Ltd, with a market cap of A$1.02 billion, demonstrates key traits appealing to penny stock investors. The company has achieved significant earnings growth of 14.2% over the past year, surpassing industry averages and reflecting strong operational performance. Its financial health is robust with short-term assets exceeding both short and long-term liabilities significantly, while debt levels have been reduced to zero from 5.5% over five years. Despite a lower net profit margin compared to last year, the company's price-to-earnings ratio suggests it offers good value relative to the broader Australian market average. Unlock comprehensive insights into our analysis of United Overseas Australia stock in this financial health report. Gain insights into United Overseas Australia's historical outcomes by reviewing our past performance report. Key Takeaways Click this link to deep-dive into the 458 companies within our ASX Penny Stocks screener. Want To Explore Some Alternatives? Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:BRE ASX:HMC and ASX:UOS. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
